Dow Jones 30 Stocks SEC Filings — January 11, 2026

12-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001187, Size: 225 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on events, transactions, or financial impacts provided in the summary. Sector not specified.

12-01-2026

Veracyte, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001384101-26-000002, Size: 186 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure event. No specific revenue, earnings, transaction values, or other quantitative metrics are disclosed in the provided filing summary.

12-01-2026

TEVA PHARMACEUTICAL INDUSTRIES LTD filed a Form 8-K on January 12, 2026 (AccNo: 0001171843-26-000174, Size: 244 KB), reporting Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary. This is a multi-item filing related to financial results.

12-01-2026

Cracker Barrel Old Country Store, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002590, Size: 2 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, financial data, transactions, or exhibits are disclosed in the provided filing summary. This is a multi-item filing with voluntary disclosure elements under Regulation FD.

12-01-2026

Katapult Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0000950103-26-000342, Size: 253 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the key position affected, appointment or resignation, reasons, named individuals, or other impacts are provided. Sector is not specified.

12-01-2026

Inspire Veterinary Partners, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003112, size: 591 KB), reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), and 9.01 (Financial Statements and Exhibits). Specific details including transaction values, parties, share counts, dollar amounts, strategic context, or financial impacts are NOT_DISCLOSED in the provided summary. Sector is not specified.

12-01-2026

Twin Vee PowerCats, Co. filed a Form 8-K on January 12, 2026 (AccNo: 0001731122-26-000038, Size: 190 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Sector is not specified. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary.

12-01-2026

Niocorp Developments Ltd filed a Form 8-K on January 12, 2026 (AccNo: 0001539497-26-000036, Size: 471 KB), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US SEC. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.

12-01-2026

Venture Global, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0002007855-26-000002, Size: 202 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or detailed outcomes are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

Enovis CORP filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001206, Size: 7 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.

12-01-2026

Kosmos Energy Ltd. filed a Form 8-K on January 12, 2026, disclosing information under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). The filing has Accession Number 0001509991-26-000005 and a size of 190 KB. No specific details on events, transactions, financial impacts, or exhibits are provided in the summary.

12-01-2026

UNITEDHEALTH GROUP INC filed a Form 8-K on January 12, 2026 (AccNo: 0000731766-26-000020, Size: 190 KB) reporting under Item 7.01 Regulation FD Disclosure. No specific details on the disclosure content, events, transactions, or financial metrics are provided in the filing summary. Sector is not specified.

12-01-2026

Vince Holding Corp. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009731, Size: 10 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specific information are disclosed in the filing summary. Sector is not specified.

12-01-2026

Palvella Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009724, Size: 26 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with sector not specified. No specific details on events, transactions, financials, or exhibits are disclosed in the provided filing summary.

12-01-2026

NovoCure Ltd filed a Form 8-K on January 12, 2026 (AccNo: 0001645113-26-000003, Size: 225 KB) reporting Item 2.02: Results of Operations and Financial Condition and Item 9.01: Financial Statements and Exhibits. This is a financial results disclosure from the US market, with sector not specified. No specific numerical financial metrics, transaction details, or further content from the filing is provided.

12-01-2026

NewtekOne, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001628280-26-001749, Size: 927 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided summary. All quantitative data, named entities, and material impacts are NOT_DISCLOSED.

12-01-2026

Global Payments Inc. filed an 8-K on January 12, 2026 (AccNo: 0001104659-26-002705, Size: 735 KB), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.01 completion of an acquisition or disposition of assets, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This indicates a merger/acquisition event for Global Payments Inc. in the US market, but no specific parties, deal structure, valuation, or financial metrics are disclosed.

12-01-2026

Fidelity National Information Services, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009759, Size: 241 KB), reporting the completion of an acquisition or disposition of assets under Item 2.01, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No details on parties involved, deal structure, valuation, or strategic rationale are explicitly stated. Sector not specified.

12-01-2026

Wave Life Sciences Ltd. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009784, size 20 MB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results announcement. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.

12-01-2026

Brookdale Senior Living Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001332349-26-000004, Size: 786 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This constitutes a multi-item voluntary financial results disclosure. No specific financial metrics, transaction values, or detailed results are provided in the filing summary.

12-01-2026

Corbus Pharmaceuticals Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009758, Size: 22 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of potentially material information and attached exhibits. No specific event details, financial metrics, or transaction information are disclosed in the provided filing summary.

12-01-2026

Harvard Bioscience Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001171843-26-000203, Size: 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure focused on Regulation FD.

12-01-2026

Avalo Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001534120-26-000003, Size: 3 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

InnovAge Holding Corp. filed a Form 8-K on January 12, 2026 (AccNo: 0001834376-26-000003, Size: 5 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the content of the Regulation FD disclosure, financial statements, exhibits, transactions, or quantitative metrics are provided in the filing summary. This is a multi-item filing likely voluntary in nature.

12-01-2026

Nuvation Bio Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009826, Size: 5 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, financial results, transaction values, or other quantitative data provided in the summary. All key transaction and financial metrics are NOT_DISCLOSED.

12-01-2026

Vir Biotechnology, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001628280-26-001768, Size: 4 MB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, transaction values, or other quantitative metrics in the summary. No core event details, strategic impacts, or guidance changes are explicitly stated.

12-01-2026

Catalyst Pharmaceuticals, Inc. filed a Form 8-K on January 12, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Accession Number: 0001193125-26-009822; File Size: 2 MB. No specific details on the disclosed information, events, transactions, financial metrics, or exhibits are provided in the filing summary.

12-01-2026

Cabaletta Bio, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009819, Size: 25 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 8.01 Other Events. No specific details on the core event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

ESTABLISHMENT LABS HOLDINGS INC. filed a Form 8-K on January 12, 2026 (AccNo: 0001688757-26-000004, Size: 276 KB) under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a financial results disclosure with no specific revenue, earnings, or other quantitative metrics provided in the filing summary. Sector is not specified.

12-01-2026

Novavax Inc filed an 8-K on January 12, 2026 (AccNo: 0001104659-26-002725, Size: 3 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.

12-01-2026

Theravance Biopharma, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002726, Size: 14 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material non-public information with attached exhibits. Sector not specified; no specific event details, financial metrics, or transaction values disclosed in the provided summary.

12-01-2026

Kyverna Therapeutics, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009810, Size: 277 KB), disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). Specific details on the officer change, including position affected, appointment/resignation status, reasons, or any quantitative data, are NOT_DISCLOSED. No sector specified.

12-01-2026

Adaptive Biotechnologies Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009840, size 8 MB), reporting Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

Bakkt Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009830, Size: 1 MB), reporting multiple material events under Items 1.01 (Entry into Material Definitive Agreement), 1.02 (Termination of Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure/Election/Appointment of Directors/Officers; Compensatory Arrangements), 5.03 (Amendments to Articles/Bylaws), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements/Exhibits). This is a multi-item mandatory filing with no specific transaction details, values, names, or financial impacts disclosed. Core events involve agreement changes, equity sales, governance shifts, and disclosures, signaling potential strategic or operational transitions.

12-01-2026

CVRx, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002728), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Results of Operations and Financial Condition (Item 2.02), Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details, transaction values, financial metrics, or named entities beyond the filer are disclosed in the provided summary. All quantitative data and core event descriptions are NOT_DISCLOSED.

12-01-2026

Senseonics Holdings, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001104659-26-002736, Size: 233 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data disclosed in the provided filing summary. Sector not specified.

12-01-2026

Disc Medicine, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009871, Size: 15 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results with no specific numerical data, transaction details, or sector disclosed in the provided information. All quantitative financial metrics are NOT_DISCLOSED.

12-01-2026

Kelly Services Inc filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009849, Size: 231 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, modifications, or disclosures provided in the available summary. All transaction values, financial metrics, and other quantitative data are NOT_DISCLOSED.

12-01-2026

Perspective Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009846, Size: 285 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative data, named entities beyond the filer, or material impacts are mentioned.

12-01-2026

Harmony Biosciences Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002731, size 7 MB), disclosing financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results announcement. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned in the provided filing summary.

12-01-2026

GLOBAL PARTNERS LP filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002740, Size: 343 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a general filing with no specific core event, transaction details, financial metrics, or numerical values disclosed in the provided summary. Sector is not specified.

12-01-2026

Allegiant Travel Co filed a Form 8-K on January 12, 2026 (AccNo: 0001140361-26-000907, Size: 8 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, disclosures, or financials provided in the summary. Sector not specified.

12-01-2026

MACOM Technology Solutions Holdings, Inc. disclosed an Officer Change via Form 8-K filed on January 12, 2026 (AccNo: 0001493594-26-000002, Size: 207 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason for change, or quantitative data are provided in the summary.

12-01-2026

Aardvark Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009862, Size: 11 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, or financial statements are provided in the filing summary. Sector not specified.

12-01-2026

VisionWave Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001731122-26-000045, Size: 398 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. Sector not specified. No details on the agreement, transaction value, parties, or exhibits provided in the summary.

12-01-2026

Ondas Holdings Inc. filed Form 8-K on 2026-01-12 (AccNo: 0001213900-26-003169, Size: 1 MB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with Item 1.01 being mandatory disclosure of a material event. No specific details, transaction values, or financial metrics are disclosed in the provided filing summary.

12-01-2026

Avalon GloboCare Corp. filed an 8-K on January 12, 2026, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Accession Number: 0001213900-26-003178, file size 228 KB. No specific details on events, transactions, or financial metrics are disclosed in the provided filing summary.

12-01-2026

Concentra Group Holdings Parent, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0002014596-26-000009, Size: 2 MB), under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned.

12-01-2026

Zimmer Biomet Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009895, size: 187 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change from US SEC source. Sector not specified.

12-01-2026

FIVE BELOW, INC filed a Form 8-K on January 12, 2026 (AccNo: 0001177609-26-000003, Size: 421 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing summary. All specifics including dollar values, percentages, and impacts are NOT_DISCLOSED.

12-01-2026

Sun Country Airlines Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009914, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Sector not specified. No specific details on the agreement, disclosures, transaction value, or financial impacts are provided in the filing summary.

12-01-2026

Theriva Biologics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002750, Size: 12 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

Orchestra BioMed Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002752, size: 211 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

Alphatec Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009910, Size: 269 KB), reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No specific revenue, earnings, transaction values, or other numerical financial metrics are disclosed in the provided filing summary. This is a standard financial results disclosure from the US SEC.

12-01-2026

Innventure, Inc. filed an 8-K on January 12, 2026 (AccNo: 0002001557-26-000002, Size: 152 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector not specified.

12-01-2026

Securetech Innovations, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001017386-26-000002, 190 KB), reporting Item 3.02 Unregistered Sales of Equity Securities and Item 9.01 Financial Statements and Exhibits. No specific details on the sales, transaction value, shares, parties, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

MainStreet Bancshares, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001437749-26-001056, Size: 188 KB) under Item 7.01 Regulation FD Disclosure. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing information. This is a voluntary disclosure of potentially material nonpublic information.

12-01-2026

KORU Medical Systems, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001161697-26-000027, size 212 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative results are disclosed in the provided filing summary. Sector not specified.

12-01-2026

Vor Biopharma Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009961, size 7 MB), disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results with no specific revenue, earnings, transaction values, or other metrics detailed in the provided information. Sector is not specified.

12-01-2026

Urban Outfitters Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010089, Size: 199 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial statements, or exhibits are provided in the filing summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

12-01-2026

Biohaven Ltd. filed an 8-K on January 12, 2026 (AccNo: 0001935979-26-000005, Size: 14 MB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Sector not specified. No core event details, transaction values, financial metrics, or other quantitative data disclosed in the provided filing summary.

12-01-2026

EQV Ventures Acquisition Corp. filed an 8-K on January 12, 2026 (AccNo: 0001213900-26-003243, Size: 32 MB) announcing a Merger/Acquisition under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

Sentient Brands Holdings Inc. filed an 8-K on January 12, 2026 (AccNo: 0001731122-26-000048), reporting under Item 1.02 termination of a material definitive agreement, Item 4.01 changes in certifying accountant, Item 5.02 departures/elections of directors/officers and compensatory arrangements, Item 8.01 other events, and Item 9.01 financial statements/exhibits. No specific transaction values, financial metrics, or named individuals/entities beyond the filer are disclosed. This is a multi-item filing signaling multiple operational and governance changes.

12-01-2026

Savers Value Village, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001883313-26-000006, Size: 251 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure with no specific revenue, earnings, transaction values, or other metrics detailed in the provided information. Sector is not specified.

12-01-2026

Avadel Pharmaceuticals PLC filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002870, Size: 266 KB), reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific details on shareholder vote outcomes, events, or exhibits provided in the summary. Sector is not specified.

12-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001880613-26-000006, Size: 255 KB), reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event from US SEC source. No core event details, transaction values, financial impacts, or other specifics are disclosed.

12-01-2026

TRUSTCO BANK CORP NY filed an 8-K on January 12, 2026 (AccNo: 0001140361-26-000965, Size: 576 KB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

12-01-2026

Diamondback Energy, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001539838-26-000003, Size: 202 KB) under Item 2.02 reporting Results of Operations and Financial Condition. No specific financial metrics, transaction values, revenue, earnings, or other quantitative details are disclosed in the provided filing information. Sector is not specified.

12-01-2026

Ambow Education Holding Ltd. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003384, Size: 266 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, appointment/resignation, reasons, or compensation are disclosed.

12-01-2026

Heritage Global Inc. announced via 8-K filing on January 12, 2026 (AccNo: 0001193125-26-010341, Size: 1 MB) entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). Additional disclosures include Regulation FD information (Item 7.01) and financial statements/exhibits (Item 9.01). No details on parties, structure, valuation, or financial impacts are provided.

12-01-2026

First Bancorp, Inc /ME/ filed a Form 8-K on January 12, 2026 (AccNo: 0000765207-26-000003, size: 126 KB), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, individuals involved, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.

12-01-2026

Shuttle Pharmaceuticals Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001861, Size: 249 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available filing summary. Sector is not specified.

12-01-2026

Bank of Marin Bancorp filed a Form 8-K on January 12, 2026, reporting under Item 8.01 Other Events. Accession number is 0001403475-26-000004 with file size 149 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.

12-01-2026

Verizon Communications Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010395, Size: 430 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or individuals are disclosed. Sector is not specified, and no quantitative financial data is mentioned.

12-01-2026

Rafael Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003411, size: 203 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No details on the specific matters submitted, vote results, or any financial implications are disclosed in the provided filing summary. This is a standard disclosure related to shareholder votes.

12-01-2026

CAVA GROUP, INC. filed a Form 8-K on January 12, 2026 (AccNo: 0001628280-26-001818, Size: 160 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.

12-01-2026

FIRST NORTHERN COMMUNITY BANCORP filed a Form 8-K on January 12, 2026 (AccNo: 0001114927-26-000002, Size: 357 KB), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are disclosed in the provided filing summary.

12-01-2026

Health Catalyst, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001636422-26-000006, Size: 434 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, transaction values, or other quantitative metrics are mentioned. Sector is not specified.

12-01-2026

Invesco Ltd. filed a Form 8-K on January 12, 2026 (AccNo: 0000914208-26-000010, Size: 228 KB) under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the filing summary. All specific impacts, values, and entities beyond the filer are NOT_DISCLOSED.

12-01-2026

Babcock & Wilcox Enterprises, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001104659-26-002884, Size: 247 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual names, appointment/resignation status, reasons, or compensation are disclosed in the provided information. Sector is not specified.

12-01-2026

Mobile Global Esports, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003416, Size: 199 KB), disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 reports financial statements and exhibits. No further details on the amendments, fiscal year change, or exhibits are provided.

12-01-2026

GeoVax Labs, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001437749-26-001113, Size: 849 KB), reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, or exhibits are disclosed in the provided information. All transaction values, financial metrics, and quantitative impacts are NOT_DISCLOSED.

12-01-2026

Assertio Holdings, Inc. filed a Form 8-K on January 12, 2026, reporting under Item 8.01 Other Events. Accession Number: 0001104659-26-002899, file size 190 KB. No details on the core event, transaction values, financial impacts, or other specifics disclosed in the provided filing summary.

12-01-2026

DELCATH SYSTEMS, INC. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-010498, Size: 15 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.

12-01-2026

RAYONIER ADVANCED MATERIALS INC. filed a Form 8-K on 2026-01-12 (AccNo: 0001597672-26-000003, Size: 197 KB) disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific names, transaction values, or additional details are provided in the filing summary. Sector not specified.

12-01-2026

5E Advanced Materials, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010363, Size: 148 KB), reporting under Item 3.02 regarding unregistered sales of equity securities. No specific details on transaction value, share count, parties involved, or financial impacts are disclosed in the provided information. This is a material event disclosure with limited available data.

12-01-2026

GlobalTech Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001477932-26-000161, Size: 179 KB), disclosing changes in certifying accountant (Item 4.01), departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific names, positions, reasons, quantitative data, or further details provided. Sector not specified.

12-01-2026

PMGC Holdings Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003480, Size: 277 KB), reporting Entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. No details on the agreement's terms, counterparties, transaction value, or financial impacts are explicitly stated in the provided filing summary. Sector is not specified.

12-01-2026

Safe & Green Development Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003507, Size: 726 KB), reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). Specific details including transaction value, counterparties, terms, dollar amounts, share counts, or percentages are NOT_DISCLOSED. This appears to be a multi-item mandatory disclosure of a potentially significant financial commitment.

12-01-2026

Travere Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001438533-26-000003, Size: 222 KB), reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. This is a financial results disclosure with no specific numerical data, transaction details, or strategic insights provided in the filing summary. Sector not specified.

12-01-2026

Evofem Biosciences, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001886, Size: 14 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the disclosure or specific exhibits are provided. Sector is not specified.

12-01-2026

Optimum Communications, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002909, size 1 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, counterparties, strategic context, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

12-01-2026

Yum China Holdings, Inc. disclosed an officer change event via SEC Form 8-K filed on January 12, 2026 (AccNo: 0001193125-26-010568, Size: 204 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, nature of change, reasons, or quantitative data are provided in the available information.

12-01-2026

GeneDx Holdings Corp. filed a Form 8-K on 2026-01-12 (AccNo: 0001818331-26-000005, Size: 5 MB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This discloses financial results but no specific revenue, earnings, transaction values, or other numerical metrics are mentioned in the provided filing summary. Sector is not specified.

12-01-2026

AMC Entertainment Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002937, Size: 240 KB) disclosing entry into a Material Definitive Agreement under Item 1.01. Item 9.01 reports Financial Statements and Exhibits. No details on the agreement's nature, parties, value, or financial impacts are provided in the summary.

12-01-2026

DIRTT Environmental Solutions Ltd filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010658, Size: 194 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary.